TOPTAQ
Live / Registered — Registered — partial invalidation of extension of protection (as of 03 Jan 2019)
What this means for you
Registered since 16 Dec 2008. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79047744
- Registration number
- 3547081
- Mark type
- Stylized text
- Filed
- 04 Oct 2007
- Published for opposition
- 30 Sept 2008
- Registered
- 16 Dec 2008
- Attorney of record
- Victoria Friedman
Goods and services
- Class 001 — Chemicals: Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, nucleic acids and enzymes other than for medical and veterinary purposes; kits comprising chemical, biochemical and biotechnological products, namely, nucleic acids and enzymes other than for medical and veterinary purposes
- Class 005 — Pharmaceuticals: [ Diagnostic preparations for medical purposes; products for human medical and veterinary medical purposes, namely, kits comprising products for human medical and veterinary medical diagnostic purposes, namely, kits comprising nucleic acid and enzymes for human medical and veterinary medical diagnostic purposes ]
Owner
- QIAGEN GmbH, 40724 Hilden, DE
- QIAGEN GmbH, DE
- QIAGEN GmbH, DE
Prosecution history
- 01 Nov 2019 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 19 Sept 2019 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 19 Sept 2019 — INVALIDATION PROCESSED
- 03 Sept 2019 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 03 Jan 2019 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 03 Jan 2019 — REGISTERED - PARTIAL SEC 71 ACCEPTED
- 05 Dec 2018 — TEAS SECTION 71 RECEIVED
- 16 Dec 2017 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 26 Oct 2017 — INTERNATIONAL REGISTRATION RENEWED
- 05 Dec 2014 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 05 Dec 2014 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 05 Dec 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Nov 2014 — TEAS SECTION 71 & 15 RECEIVED
- 07 Jan 2013 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 01 Apr 2009 — FINAL DISPOSITION NOTICE SENT TO IB